A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations.

导出 LinkOut

翻译打印收藏纠错

第一作者： Hua,Ling

第一单位： School of Medicine, Cardiac Center of Creighton University, Omaha, NE, USA.

作者： Hua,Ling ^[1] ; John T,Luoma ^[2] ; Daniel,Hilleman ^[3]

作者单位： School of Medicine, Cardiac Center of Creighton University, Omaha, NE, USA. ^[1] Department of Cardiovascular Science, AbbVie (formerly Abbott Laboratories), North Chicago, IL, USA. ^[2] School of Pharmacy and Health Professions, Cardiac Center of Creighton University, Omaha, NE, USA. ^[3]

关键词 Bioavailability Fenofibrate Fenofibric acid Formulation Mixed dyslipidemia Triglycerides

DOI 10.4021/cr270w

PMID 28352420

发布时间 2024-05-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览57

Cardiology research

2013年4卷2期

47-55页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations.

Cardiology research

相似文献

Cardiology research

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A Review of Currently Available Fenofibrate and Fenofibric Acid Formulations.

Cardiology research

相似文献

Cardiology research

相关期刊

检索历史清除